Affinage · Plasmodium

LRR1

PF3D7_1032800 · leucine-rich repeat protein 1

Annotated
2026-09-08
4 papers in source corpus 3 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LRR1 (PF3D7_1032800) is a leucine-rich repeat protein of Plasmodium that functions as a regulator of Protein Phosphatase type 1 (PP1), coupling phosphatase control to cell cycle progression and parasite development (PMID:16629662, PMID:35920043). In P. falciparum, LRR1 physically binds PfPP1 and inhibits its phosphatase activity in vitro, and in a heterologous Xenopus oocyte system LRR1 engages endogenous PP1 to drive progression through the G2/M checkpoint, inducing germinal vesicle breakdown in a manner phenocopying PP1 inhibition (PMID:16629662). In P. berghei, the orthologue forms a PP1 complex across both asexual and sexual stages and inhibits PP1 activity, and its depletion impairs oocyst development in the mosquito (PMID:35920043). Within this complex, LRR1 controls the phosphorylation status of the PP1 regulator Inhibitor 3, which becomes drastically hypophosphorylated upon LRR1 depletion, linking LRR1–PP1 activity to transmission-stage development (PMID:35920043).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2006 Medium

    It was unknown what regulated PfPP1 in the parasite; identifying LRR1 as a direct binding partner and inhibitor established a specific molecular mechanism for controlling phosphatase activity.

    Evidence GST pull-down, complex detection in parasite extracts, and in vitro phosphatase assay in P. falciparum

    PMID:16629662

    Open questions at the time
    • Single lab, single study
    • Binding site and stoichiometry on PP1 not defined
    • In vivo consequence in the parasite not tested
  2. 2006 Medium

    Whether LRR1's PP1 inhibition had functional consequences for cell cycle control was untested; a Xenopus oocyte assay showed LRR1 drives G2/M progression, tying PP1 modulation to checkpoint control.

    Evidence Xenopus oocyte microinjection functional assay with okadaic acid and anti-PP1 antibody controls

    PMID:16629662

    Open questions at the time
    • Heterologous system, not native parasite cell cycle
    • Direct demonstration in Plasmodium G2/M lacking
    • Downstream substrates unidentified
  3. 2007 Low

    The genomic context and expression timing of LRR1 were undefined; cloning and qPCR placed it among 14 parasite LRR proteins and showed peak transcription in late intraerythrocytic stages consistent with a cell-cycle role.

    Evidence Genome analysis, cDNA cloning/sequencing, and real-time qPCR in P. falciparum

    PMID:17689674

    Open questions at the time
    • Transcript-level only, no protein or functional follow-up
    • Number of LRR motifs given as a range (4–10)
    • Does not address mechanism
  4. 2022 High

    It was unknown whether the LRR1–PP1 interaction was conserved and physiologically required in vivo; genetic loss-of-function in P. berghei showed the complex forms across life stages and is needed for oocyst development.

    Evidence Co-immunoprecipitation across asexual and sexual stages, in vitro phosphatase assay, and genetic depletion with oocyst phenotype in P. berghei

    PMID:35920043

    Open questions at the time
    • Mechanism linking PP1 inhibition to oocyst development not fully resolved
    • Asexual essentiality not clarified by the phenotype
    • Single lab
  5. 2022 Medium

    The downstream targets of the LRR1–PP1 complex were unknown; interactome and phosphoproteomics identified Inhibitor 3 as a complex member whose phosphorylation depends on LRR1, connecting the complex to a defined regulatory node.

    Evidence Interactome mass spectrometry and phospho-proteomics in PbLRR1-depleted P. berghei

    PMID:35920043

    Open questions at the time
    • Not reconstituted in vitro
    • Kinase acting on I3 not identified
    • Causal chain from I3 phosphorylation to phenotype not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • How LRR1 inhibition of PP1 is regulated during the parasite life cycle and which native substrates translate this into cell cycle and developmental outcomes remain unresolved.
  • No structural model of the LRR1–PP1 interface
  • Native parasite substrates of the complex undefined
  • Regulation of LRR1 activity across stages unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
LRR1–PP1 complexLRR1–PP1–Inhibitor 3 complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 LRR1 (PfLRR1) physically interacts with PfPP1 (protein phosphatase type 1) as shown by GST pull-down assay, and the LRR1–PfPP1 complex is detectable in parasite extracts; LRR1 inhibits PfPP1 phosphatase activity in vitro. GST pull-down assay; detection of complex in parasite extracts; in vitro phosphatase activity assay Molecular microbiology Medium 16629662
2006 In Xenopus oocyte functional assays, LRR1 (PfLRR1) interacted with endogenous Xenopus PP1 and promoted progression through the G2/M cell cycle checkpoint, inducing germinal vesicle breakdown (GVBD), phenocopying anti-PP1 antibody treatment or okadaic acid, indicating LRR1 regulates cell cycle by binding to and modulating PP1 activity. Xenopus oocyte microinjection/functional cell cycle assay; comparison with okadaic acid and anti-PP1 antibody controls Molecular microbiology Medium 16629662
2022 PbLRR1 (P. berghei orthologue of LRR1) forms a complex with PbPP1 in both asexual and sexual stages of P. berghei and inhibits PbPP1 phosphatase activity; depletion of PbLRR1 adversely affects oocyst development in mosquitoes. Co-immunoprecipitation (complex detection in asexual and sexual stages); in vitro phosphatase activity assay; genetic depletion (knock-down/knock-out) with phenotypic readout (oocyst development) Open biology High 35920043
2022 Interactome and phospho-proteomics analysis of PbLRR1-depleted P. berghei parasites revealed that Inhibitor 3 (I3), a direct PP1 interactor, is drastically hypophosphorylated upon PbLRR1 depletion, and I3 was detected in the LRR1–PP1 complex, suggesting the LRR1–PP1 complex controls the phosphorylation status of I3 and thereby contributes to oocyst development. Interactome mass spectrometry; phospho-proteomics in PbLRR1-depleted parasites Open biology Medium 35920043
2007 LRR1 (PfLRR1) is one of 14 LRR-containing proteins encoded in the P. falciparum genome; molecular cloning and cDNA sequencing confirmed it contains 4–10 LRR motifs, and real-time quantitative PCR showed its transcript is highly expressed in late intraerythrocytic stages (late trophozoites and schizonts). Genome analysis; molecular cloning and cDNA sequencing; real-time quantitative PCR Molecular and biochemical parasitology Low 17689674

Source papers

Stage 0 corpus · 4 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Regulation of protein phosphatase type 1 and cell cycle progression by PfLRR1, a novel leucine-rich repeat protein of the human malaria parasite Plasmodium falciparum. Molecular microbiology 34 16629662
2012 Inhibition of protein-protein interactions in Plasmodium falciparum: future drug targets. Current pharmaceutical design 10 22607144
2007 Census, molecular characterization and developmental expression of Leucine-Rich-Repeat proteins in Plasmodium falciparum. Molecular and biochemical parasitology 7 17689674
2022 Plasmodium berghei leucine-rich repeat protein 1 downregulates protein phosphatase 1 activity and is required for efficient oocyst development. Open biology 5 35920043